Gian Parkash Aggarwal sold 15.5 lakh shares of Innova Captab for ₹167.41 Cr at ₹1,080.04 apiece through a market sale. This reduced the stake from 10.80% to 8.09%.
An integrated pharmaceutical company operating across India's drug manufacturing and distribution value chain. Innova Captab develops, manufactures, and markets a diverse portfolio of pharmaceutical formulations for both domestic and international markets. The company maintains vertically integrated operations spanning multiple therapeutic areas, enabling control over production processes, quality management, and supply chain efficiency within the competitive Indian pharmaceutical sector.
